Eiger BioPharmaceuticals Inc Shares Approach 52-Week Low - Market Mover
The shares closed 0.6% above its 52-week low of $4.95, with trading volume lower than its 30 day average
Jan 07, 2022 by Kwhen Finance Editors
Eiger BioPharmaceuticals Inc (EIGR) shares closed today at 0.6% above its 52 week low of $4.95, giving the company a market cap of $169M. The stock is currently down 4.0% year-to-date, down 60.4% over the past 12 months, and down 57.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 47.9% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | -0.4 | -4.0 | -60.4 | -63.1 | 0.6 |
| Dow Jones Industrial Average | -0.5 | 0.2 | 21.9 | -1.4 | 24.0 |
| S&P 500 Index | -0.1 | -1.4 | 27.8 | -2.5 | 28.8 |
| Health Care | -1.1 | -3.5 | 19.1 | -4.6 | 22.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -332.2%
- The company's stock price performance over the past 12 months lags the peer average by 399.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | EIGR | 0 | -4.0 | -60.4 | -63.1 | 0.6 |
| Peer Avg | N/A | 4.8 | 1.7 | -12.1 | -21.5 | 12.6 |
| National Research Corp | NRC | 29.3 | 0.0 | -2.5 | -24.5 | 6.8 |
| Nymox Pharmaceutical Corp | NYMX | -10.2 | 6.9 | -45.9 | -61.4 | 43.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: